Item 2.02 Results of Operations and Financial Condition.

The following information and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

On January 11, 2021, Magenta Therapeutics, Inc. issued a press release providing a business update including highlights of recent progress across several programs and platforms, preliminary unaudited financial results for the full year ended December 31, 2020 and projected cash runway. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:



The following exhibit relating to Item 2.02 shall be deemed furnished, and not
filed:



99.1      Press Release dated January 11, 2021.

104     Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses